Update on the genetics and genomics of PBC
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Despite recent progress, the pathogenic mechanisms governing PBC development, treatment response and outcome remain unknown. This deficiency is in large part due to the complex nature of PBC, wherein various environmental factors may be capable of prompting disease, but only in the context of underlying genetic susceptibility. Identification of genomic loci containing these heritable risk factors has been slowed by the rarity and late onset of PBC, which has made difficult the collection of sufficient numbers of patients and family members for meaningful genetic analyses. Advancements in our ability to catalog the genetic variation in large numbers of individuals at a genome-wide scale, coupled with unprecedented efforts to recruit PBC patients for genetic study, positions us to generate data that could fundamentally change our understanding of PBC and lead to clinical innovation. Indeed, the first genome-wide association study for PBC has been published, in which multiple genes involved with IL12 signaling, a pathway that is being targeted in treatment of other inflammatory conditions, were implicated in disease. However, this study was relatively small in the genome-wide milieu and a significantly expanded effort will be necessary to truly elucidate the genetic architecture of PBC. Moving ahead, cooperation between the groups collecting biospecimens and generating genome-wide data from large numbers of patients with PBC will be essential, not only to increase power for fine mapping and future studies of rare variants and epistasis; but to streamline efforts to perform functional validation of novel discoveries. Here we provide a brief update of the current state of genetics in PBC to form a basis for understanding the considerable progress that is likely to be made in the coming years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Are Rare Variants Responsible for Susceptibility to Complex Diseases?
Pritchard, J. K. (2001) · The American Journal of Human Genetics · doi:10.1086/321272 · Cited by 1,197 · cited 2×
“Two models are regularly invoked to describe the genetic architecture of complex diseases; the common diseaseecommon variant [5] and the common diseaseerare variant [6] hypotheses.”
BackgroundThe New Genomics: Global Views of Biology
Lander, E. S. (1996) · Science · doi:10.1126/science.274.5287.536 · Cited by 1,174 · cited 1×
“Two models are regularly invoked to describe the genetic architecture of complex diseases; the common diseaseecommon variant [5] and the common diseaseerare variant [6] hypotheses.”
BackgroundKaplan, M. M., & Gershwin, M. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043898 · Cited by 1,144
Gershwin, E. M., Selmi, C., Worman, H. J., Gold, E. B., Watnik, M., Utts, J., Lindor, K. D., Kaplan, M. M., & Vierling, J. M. (2005) · Hepatology · doi:10.1002/hep.20907 · Cited by 621
Primary Biliary Cirrhosis Associated with HLA, IL12A, and IL12RB2 Variants
Hirschfield, G. M., Liu, X., Xu, C., Lu, Y., Xie, G., Lu, Y., Gu, X., Walker, E. J., Jing, K., Juran, B. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810440 · Cited by 594 · cited 8×
“Strong linkage disequilibrium (LD) in the region, the fact that this haplotype is somewhat less frequent than the DRB1*0801 allele, and data that the Japanese risk haplotype is DRB1*0803e DQA1*0103 DQB1*0601[19] points to the DRB1*08 allele family as the likely HLA determinant of PBC risk, although this conjecture is…”
BackgroundInfluentialSelf-citationPrimary biliary cirrhosis in monozygotic and dizygotic twins: Genetics, epigenetics, and environment
Selmi, C., Mayo, M. J., Bach, N., Ishibashi, H., Invernizzi, P., Gish, R. G., Gordon, S. C., Wright, H. I., Zweiban, B., Podda, M., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.05.005 · Cited by 480
Apotopes and the biliary specificity of primary biliary cirrhosis†
Lleo, A., Selmi, C., Invernizzi, P., Podda, M., Coppel, R. L., Mackay, I. R., Gores, G. J., Ansari, A. A., Van de Water, J., & Gershwin, M. E. (2009) · Hepatology · doi:10.1002/hep.22736 · Cited by 222 · cited 1×
“Recent findings indicate that biliary targeting of the autoimmune attack is due to the presence of intact immunoreactive PDC-E2 within apoptotic blebs of biliary epithelial cells (BECs); a feature that appears to be unique to BECs but not specific to PBC [4].”
BackgroundFamilial primary biliary cirrhosis reassessed: a geographically-based population study
Jones, D. E., Watt, F. E., Metcalf, J. V., Bassendine, M. F., & James, O. F. W. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80097-x · Cited by 213 · cited 1×
“5 [11], on the same order of magnitude as other autoimmune diseases [9].”
BackgroundLazaridis, K. N., Juran, B. D., Boe, G. M., Slusser, J. P., de Andrade, M., Homburger, H. A., Ghosh, K., Dickson, R. E., Lindor, K. D., & Petersen, G. M. (2007) · Hepatology · doi:10.1002/hep.21749 · Cited by 128 · cited 1×
“In addition to increased prevalence of PBC itself, the presence of AMA has also been shown to aggregate in first degree relatives of afflicted individuals, regardless of familial history of PBC [13].”
BackgroundSelf-citationKisand, K. E., Metsküla, K., Kisand, K. V., Kivik, T., Gershwin, M. E., & Uibo, R. (2001) · Journal of Gastroenterology · doi:10.1007/s005350170111 · Cited by 56
Cited by
The X chromosome and immune associated genes
Bianchi, I., Lleo, A., Gershwin, M. E., & Invernizzi, P. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.11.012 · Cited by 378
Twin studies in autoimmune disease: Genetics, gender and environment
Bogdanos, D. P., Smyk, D. S., Rigopoulou, E. I., Mytilinaiou, M. G., Heneghan, M. A., Selmi, C., & Eric Gershwin, M. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.11.003 · Cited by 271
Juran, B. D., Hirschfield, G. M., Invernizzi, P., Atkinson, E. J., Li, Y., Xie, G., Kosoy, R., Ransom, M., Sun, Y., Bianchi, I., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds359 · Cited by 150
“As for most other autoimmune diseases, underlying genetic variation is considered key to the etiology of PBC (7).”
BackgroundSelf-citationNinomiya, M., Kondo, Y., Funayama, R., Nagashima, T., Kogure, T., Kakazu, E., Kimura, O., Ueno, Y., Nakayama, K., & Shimosegawa, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066086 · Cited by 83
“Recently, many studies have examined several PBC associations with genes and there have been significant differences in the genetic risk loci reported [21] [30].”
BackgroundNakamura, M., Kondo, H., Tanaka, A., Komori, A., Ito, M., Yamamoto, K., Ohira, H., Zeniya, M., Hashimoto, E., Honda, M., et al. (2015) · Hepatology Research · doi:10.1111/hepr.12423 · Cited by 49
Metadata
- Authors
- Juran, B. D., & Lazaridis, K. N.
- Venue
- Journal of Autoimmunity
- Publisher
- Elsevier BV
- Published
- 2010-11
- Volume
- 35
- Issue
- 3
- Pages
- 181-187
- ISSN
- 0896-8411 (ISSN-L)
- OpenAlex
- W1987378677
- Cited by
- 30
- References
- 10
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.